Jonathan Nakashima

Jonathan Nakashima

Company: Oncology

Job title: Chief Scientific Officer

Seminars:

Discussion/Q&A 4:50 pm

Read more

day: Day One

Orthotopic Patient-Derived-Xenograft Models Guide Individualized Precision Oncology Therapy 3:50 pm

Orthotopic PDX (O-PDX) models can be derived from needle or surgical biopsiez In vivo pharmacology studies accurately predict patient response The O-PDX methodology provides a platform for autologous humanization and precision IO studiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.